Education
About Us
Working with TipRanks
Follow Us
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
RESEARCH TOOLSreports
Total Valuation
Sun Pharmaceutical Industries Limited has a market cap or net worth of ₹4.05T. The enterprise value is ₹4.45T.
Market Cap₹4.05T
Enterprise Value₹4.45T
Share Statistics
Sun Pharmaceutical Industries Limited has 2.40B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2.40B
Owened by Insiders
Owened by Instutions
Financial Efficiency
Sun Pharmaceutical Industries Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Sun Pharmaceutical Industries Limited is ―. Sun Pharmaceutical Industries Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Sun Pharmaceutical Industries Limited had revenue of ₹487.96B and earned ₹103.89B in profits. Earnings per share was ₹43.34.
Revenue₹487.96B
Gross Profit₹321.56B
Operating Income₹113.89B
Pretax Income₹120.30B
Net Income₹103.89B
EBITDA148.10B
Earnings Per Share (EPS)43.34
Cash Flow
In the last 12 months, operating cash flow was ₹25.10B and capital expenditures ₹0.00, giving a free cash flow of ₹25.10B billion.
Operating Cash Flow₹25.10B
Free Cash Flow₹25.10B
Free Cash Flow per Share₹10.46
Dividends & Yields
Sun Pharmaceutical Industries Limited pays an annual dividend of ₹15.50, resulting in a dividend yield of 0.92%
Dividend Per Share₹15.50
Dividend Yield0.92%
Payout Ratio10.12%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change10.51%
50-Day Moving Average1.70K
200-Day Moving Average1.75K
Relative Strength Index (RSI)47.70
Average Volume (3m)73.73K
Important Dates
Sun Pharmaceutical Industries Limited upcoming earnings date is Jun 3, 2025, TBA.
Last Earnings DateJan 31, 2025
Next Earnings DateJun 3, 2025
Ex-Dividend DateFeb 6, 2025
Financial Position
Sun Pharmaceutical Industries Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Sun Pharmaceutical Industries Limited has paid ₹15.24B in taxes.
Income Tax₹15.24B
Effective Tax Rate―
Enterprise Valuation
Sun Pharmaceutical Industries Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Sun Pharmaceutical Industries Limited has ₹190.90B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹190.90B billion.
Cash & Marketable Securities₹190.90B
Total Debt₹0.00
Net Cash-₹190.90B
Net Cash Per Share-₹79.57
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Sun Pharmaceutical Industries Limited is ₹2027.78, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹2027.78
Price Target Upside25.96%
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast
EPS Growth Forecast